世界のエトリコキシブ中間体市場予測 2021年-2026年

【英語タイトル】Global Etoricoxib Intermediate Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21MY9526)・商品コード:LPI21MY9526
・発行会社(調査会社):LP Information
・発行日:2021年5月
・ページ数:133
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥494,100見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥741,150見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥988,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「エトリコキシブ中間体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、社内製造、受託製造組織など、用途別には、関節リウマチ、乾癬性関節炎、変形性関節症、強直性脊椎炎、慢性腰痛、急性痛、その他などにセグメント区分してまとめました。エトリコキシブ中間体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・エトリコキシブ中間体の世界市場概要(サマリー)
・エトリコキシブ中間体の企業別販売量・売上
・エトリコキシブ中間体の企業別市場シェア
・エトリコキシブ中間体の世界市場規模 2016年-2021年:種類別(社内製造、受託製造組織)
・エトリコキシブ中間体の世界市場規模 2016年-2021年:用途別(関節リウマチ、乾癬性関節炎、変形性関節症、強直性脊椎炎、慢性腰痛、急性痛、その他)
・エトリコキシブ中間体の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・エトリコキシブ中間体のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・エトリコキシブ中間体のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・エトリコキシブ中間体の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・エトリコキシブ中間体市場の成長要因・課題・動向
・エトリコキシブ中間体の世界市場予測 2021年-2026年
・エトリコキシブ中間体の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・エトリコキシブ中間体のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・エトリコキシブ中間体のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・エトリコキシブ中間体の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・エトリコキシブ中間体の世界市場予測:種類別(社内製造、受託製造組織)
・エトリコキシブ中間体の世界市場予測:用途別(関節リウマチ、乾癬性関節炎、変形性関節症、強直性脊椎炎、慢性腰痛、急性痛、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Etoricoxib Intermediate will have significant change from previous year. By the most conservative estimates of global Etoricoxib Intermediate market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Etoricoxib Intermediate market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Etoricoxib Intermediate market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
n-House Manufacturing
Contract Manufacturing Organizations

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Ankylosing Spondylitis
Chronic Low Back Pain
Acute Pain
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bayer
Novacap
Abbott
Pfizer
Geri-Care
Perrigo
Kopran
Merck
Sun Pharmaceutical
GlaxoSmithKline

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Etoricoxib Intermediate Consumption 2016-2026
2.1.2 Etoricoxib Intermediate Consumption CAGR by Region
2.2 Etoricoxib Intermediate Segment by Type
2.2.1 n-House Manufacturing
2.2.2 Contract Manufacturing Organizations
2.3 Etoricoxib Intermediate Sales by Type
2.3.1 Global Etoricoxib Intermediate Sales Market Share by Type (2016-2021)
2.3.2 Global Etoricoxib Intermediate Revenue and Market Share by Type (2016-2021)
2.3.3 Global Etoricoxib Intermediate Sale Price by Type (2016-2021)
2.4 Etoricoxib Intermediate Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Psoriatic Arthritis
2.4.3 Osteoarthritis
2.4.4 Ankylosing Spondylitis
2.4.5 Chronic Low Back Pain
2.4.6 Acute Pain
2.4.7 Others
2.5 Etoricoxib Intermediate Sales by Application
2.5.1 Global Etoricoxib Intermediate Sale Market Share by Application (2016-2021)
2.5.2 Global Etoricoxib Intermediate Revenue and Market Share by Application (2016-2021)
2.5.3 Global Etoricoxib Intermediate Sale Price by Application (2016-2021)

3 Global Etoricoxib Intermediate by Company
3.1 Global Etoricoxib Intermediate Sales Market Share by Company
3.1.1 Global Etoricoxib Intermediate Sales by Company (2019-2021)
3.1.2 Global Etoricoxib Intermediate Sales Market Share by Company (2019-2021)
3.2 Global Etoricoxib Intermediate Revenue Market Share by Company
3.2.1 Global Etoricoxib Intermediate Revenue by Company (2019-2021)
3.2.2 Global Etoricoxib Intermediate Revenue Market Share by Company (2019-2021)
3.3 Global Etoricoxib Intermediate Sale Price by Company
3.4 Global Manufacturers Etoricoxib Intermediate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Etoricoxib Intermediate Product Location Distribution
3.4.2 Players Etoricoxib Intermediate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Etoricoxib Intermediate by Region
4.1 Global Etoricoxib Intermediate by Region
4.1.1 Global Etoricoxib Intermediate Sales by Region
4.1.2 Global Etoricoxib Intermediate Revenue by Region
4.2 Americas Etoricoxib Intermediate Sales Growth
4.3 APAC Etoricoxib Intermediate Sales Growth
4.4 Europe Etoricoxib Intermediate Sales Growth
4.5 Middle East & Africa Etoricoxib Intermediate Sales Growth

5 Americas
5.1 Americas Etoricoxib Intermediate Sales by Country
5.1.1 Americas Etoricoxib Intermediate Sales by Country (2016-2021)
5.1.2 Americas Etoricoxib Intermediate Revenue by Country (2016-2021)
5.2 Americas Etoricoxib Intermediate Sales by Type
5.3 Americas Etoricoxib Intermediate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Etoricoxib Intermediate Sales by Region
6.1.1 APAC Etoricoxib Intermediate Sales by Region (2016-2021)
6.1.2 APAC Etoricoxib Intermediate Revenue by Region (2016-2021)
6.2 APAC Etoricoxib Intermediate Sales by Type
6.3 APAC Etoricoxib Intermediate Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Etoricoxib Intermediate by Country
7.1.1 Europe Etoricoxib Intermediate Sales by Country (2016-2021)
7.1.2 Europe Etoricoxib Intermediate Revenue by Country (2016-2021)
7.2 Europe Etoricoxib Intermediate Sales by Type
7.3 Europe Etoricoxib Intermediate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Etoricoxib Intermediate by Country
8.1.1 Middle East & Africa Etoricoxib Intermediate Sales by Country (2016-2021)
8.1.2 Middle East & Africa Etoricoxib Intermediate Revenue by Country (2016-2021)
8.2 Middle East & Africa Etoricoxib Intermediate Sales by Type
8.3 Middle East & Africa Etoricoxib Intermediate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Etoricoxib Intermediate Distributors
10.3 Etoricoxib Intermediate Customer

11 Global Etoricoxib Intermediate Market Forecast
11.1 Global Etoricoxib Intermediate Forecast by Region
11.1.1 Global Etoricoxib Intermediate Forecast by Regions (2021-2026)
11.2.2 Global Etoricoxib Intermediate Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Etoricoxib Intermediate Forecast by Type
11.7 Global Etoricoxib Intermediate Forecast by Application

12 Key Players Analysis
12.1 Bayer
12.1.1 Bayer Bayer Company Information
12.1.2 Bayer Etoricoxib Intermediate Product Offered
12.1.3 Bayer Etoricoxib Intermediate Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bayer Main Business Overview
12.1.5 Bayer Latest Developments
12.2 Novacap
12.2.1 Novacap Company Information
12.2.2 Novacap Etoricoxib Intermediate Product Offered
12.2.3 Novacap Etoricoxib Intermediate Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novacap Main Business Overview
12.2.5 Novacap Latest Developments
12.3 Abbott
12.3.1 Abbott Company Information
12.3.2 Abbott Etoricoxib Intermediate Product Offered
12.3.3 Abbott Etoricoxib Intermediate Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Abbott Main Business Overview
12.3.5 Abbott Latest Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Etoricoxib Intermediate Product Offered
12.4.3 Pfizer Etoricoxib Intermediate Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Pfizer Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Geri-Care
12.5.1 Geri-Care Company Information
12.5.2 Geri-Care Etoricoxib Intermediate Product Offered
12.5.3 Geri-Care Etoricoxib Intermediate Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Geri-Care Main Business Overview
12.5.5 Geri-Care Latest Developments
12.6 Perrigo
12.6.1 Perrigo Company Information
12.6.2 Perrigo Etoricoxib Intermediate Product Offered
12.6.3 Perrigo Etoricoxib Intermediate Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Perrigo Main Business Overview
12.6.5 Perrigo Latest Developments
12.7 Kopran
12.7.1 Kopran Company Information
12.7.2 Kopran Etoricoxib Intermediate Product Offered
12.7.3 Kopran Etoricoxib Intermediate Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Kopran Main Business Overview
12.7.5 Kopran Latest Developments
12.8 Merck
12.8.1 Merck Company Information
12.8.2 Merck Etoricoxib Intermediate Product Offered
12.8.3 Merck Etoricoxib Intermediate Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Merck Main Business Overview
12.8.5 Merck Latest Developments
12.9 Sun Pharmaceutical
12.9.1 Sun Pharmaceutical Company Information
12.9.2 Sun Pharmaceutical Etoricoxib Intermediate Product Offered
12.9.3 Sun Pharmaceutical Etoricoxib Intermediate Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Sun Pharmaceutical Main Business Overview
12.9.5 Sun Pharmaceutical Latest Developments
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Company Information
12.10.2 GlaxoSmithKline Etoricoxib Intermediate Product Offered
12.10.3 GlaxoSmithKline Etoricoxib Intermediate Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 GlaxoSmithKline Main Business Overview
12.10.5 GlaxoSmithKline Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Etoricoxib Intermediate Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of n-House Manufacturing
Table 3. Major Players of Contract Manufacturing Organizations
Table 4. Global Etoricoxib Intermediate Sales by Type (2016-2021) & (MT)
Table 5. Global Etoricoxib Intermediate Sales Market Share by Type (2016-2021)
Table 6. Global Etoricoxib Intermediate Revenue by Type (2016-2021) & ($ million)
Table 7. Global Etoricoxib Intermediate Revenue Market Share by Type (2016-2021)
Table 8. Global Etoricoxib Intermediate Sale Price by Type (2016-2021)
Table 9. Global Etoricoxib Intermediate Sales by Application (2016-2021) & (MT)
Table 10. Global Etoricoxib Intermediate Sales Market Share by Application (2016-2021)
Table 11. Global Etoricoxib Intermediate Value by Application (2016-2021)
Table 12. Global Etoricoxib Intermediate Revenue Market Share by Application (2016-2021)
Table 13. Global Etoricoxib Intermediate Sale Price by Application (2016-2021)
Table 14. Global Etoricoxib Intermediate Sales by Company (2019-2021) & (MT)
Table 15. Global Etoricoxib Intermediate Sales Market Share by Company (2019-2021)
Table 16. Global Etoricoxib Intermediate Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Etoricoxib Intermediate Revenue Market Share by Company (2019-2021)
Table 18. Global Etoricoxib Intermediate Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Etoricoxib Intermediate Producing Area Distribution and Sales Area
Table 20. Players Etoricoxib Intermediate Products Offered
Table 21. Etoricoxib Intermediate Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Etoricoxib Intermediate Sales by Region (2016-2021) (MT)
Table 25. Global Etoricoxib Intermediate Sales Market Share by Region (2016-2021)
Table 26. Global Etoricoxib Intermediate Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Etoricoxib Intermediate Revenue Market Share by Region (2016-2021)
Table 28. Americas Etoricoxib Intermediate Sales by Country (2016-2021) & (MT)
Table 29. Americas Etoricoxib Intermediate Sales Market Share by Country (2016-2021)
Table 30. Americas Etoricoxib Intermediate Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Etoricoxib Intermediate Revenue Market Share by Country (2016-2021)
Table 32. Americas Etoricoxib Intermediate Sales by Type (2016-2021) & (MT)
Table 33. Americas Etoricoxib Intermediate Sales Market Share by Type (2016-2021)
Table 34. Americas Etoricoxib Intermediate Sales by Application (2016-2021) & (MT)
Table 35. Americas Etoricoxib Intermediate Sales Market Share by Application (2016-2021)
Table 36. APAC Etoricoxib Intermediate Sales by Region (2016-2021) & (MT)
Table 37. APAC Etoricoxib Intermediate Sales Market Share by Region (2016-2021)
Table 38. APAC Etoricoxib Intermediate Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Etoricoxib Intermediate Revenue Market Share by Region (2016-2021)
Table 40. APAC Etoricoxib Intermediate Sales by Type (2016-2021) & (MT)
Table 41. APAC Etoricoxib Intermediate Sales Market Share by Type (2016-2021)
Table 42. APAC Etoricoxib Intermediate Sales by Application (2016-2021) & (MT)
Table 43. APAC Etoricoxib Intermediate Sales Market Share by Application (2016-2021)
Table 44. Europe Etoricoxib Intermediate Sales by Country (2016-2021) & (MT)
Table 45. Europe Etoricoxib Intermediate Sales Market Share by Country (2016-2021)
Table 46. Europe Etoricoxib Intermediate Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Etoricoxib Intermediate Revenue Market Share by Country (2016-2021)
Table 48. Europe Etoricoxib Intermediate Sales by Type (2016-2021) & (MT)
Table 49. Europe Etoricoxib Intermediate Sales Market Share by Type (2016-2021)
Table 50. Europe Etoricoxib Intermediate Sales by Application (2016-2021) & (MT)
Table 51. Europe Etoricoxib Intermediate Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Etoricoxib Intermediate Sales by Country (2016-2021) & (MT)
Table 53. Middle East & Africa Etoricoxib Intermediate Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Etoricoxib Intermediate Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Etoricoxib Intermediate Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Etoricoxib Intermediate Sales by Type (2016-2021) & (MT)
Table 57. Middle East & Africa Etoricoxib Intermediate Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Etoricoxib Intermediate Sales by Application (2016-2021) & (MT)
Table 59. Middle East & Africa Etoricoxib Intermediate Sales Market Share by Application (2016-2021)
Table 60. Global Etoricoxib Intermediate Sales Forecast by Type (2021-2026) & (MT)
Table 61. Global Etoricoxib Intermediate Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Etoricoxib Intermediate Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Etoricoxib Intermediate Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Etoricoxib Intermediate Sales Forecast by Application (2021-2026) & (MT)
Table 65. Global Etoricoxib Intermediate Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Etoricoxib Intermediate Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Etoricoxib Intermediate Revenue Market Share Forecast by Application (2021-2026)
Table 68. Bayer Basic Information, Etoricoxib Intermediate Manufacturing Base, Sales Area and Its Competitors
Table 69. Bayer Etoricoxib Intermediate Product Offered
Table 70. Bayer Etoricoxib Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 71. Bayer Main Business
Table 72. Bayer Latest Developments
Table 73. Novacap Basic Information, Etoricoxib Intermediate Manufacturing Base, Sales Area and Its Competitors
Table 74. Novacap Etoricoxib Intermediate Product Offered
Table 75. Novacap Etoricoxib Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 76. Novacap Main Business
Table 77. Novacap Latest Developments
Table 78. Abbott Basic Information, Etoricoxib Intermediate Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Etoricoxib Intermediate Product Offered
Table 80. Abbott Etoricoxib Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 81. Abbott Main Business
Table 82. Abbott Latest Developments
Table 83. Pfizer Basic Information, Etoricoxib Intermediate Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Etoricoxib Intermediate Product Offered
Table 85. Pfizer Etoricoxib Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Geri-Care Basic Information, Etoricoxib Intermediate Manufacturing Base, Sales Area and Its Competitors
Table 89. Geri-Care Etoricoxib Intermediate Product Offered
Table 90. Geri-Care Etoricoxib Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 91. Geri-Care Main Business
Table 92. Geri-Care Latest Developments
Table 93. Perrigo Basic Information, Etoricoxib Intermediate Manufacturing Base, Sales Area and Its Competitors
Table 94. Perrigo Etoricoxib Intermediate Product Offered
Table 95. Perrigo Etoricoxib Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 96. Perrigo Main Business
Table 97. Perrigo Latest Developments
Table 98. Kopran Basic Information, Etoricoxib Intermediate Manufacturing Base, Sales Area and Its Competitors
Table 99. Kopran Etoricoxib Intermediate Product Offered
Table 100. Kopran Etoricoxib Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 101. Kopran Main Business
Table 102. Kopran Latest Developments
Table 103. Merck Basic Information, Etoricoxib Intermediate Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Etoricoxib Intermediate Product Offered
Table 105. Merck Etoricoxib Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Sun Pharmaceutical Basic Information, Etoricoxib Intermediate Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharmaceutical Etoricoxib Intermediate Product Offered
Table 110. Sun Pharmaceutical Etoricoxib Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 111. Sun Pharmaceutical Main Business
Table 112. Sun Pharmaceutical Latest Developments
Table 113. GlaxoSmithKline Basic Information, Etoricoxib Intermediate Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline Etoricoxib Intermediate Product Offered
Table 115. GlaxoSmithKline Etoricoxib Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 116. GlaxoSmithKline Main Business
Table 117. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Picture of Etoricoxib Intermediate
Figure 2. Etoricoxib Intermediate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Etoricoxib Intermediate Sales Growth Rate 2016-2026 (MT)
Figure 7. Global Etoricoxib Intermediate Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Etoricoxib Intermediate Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of n-House Manufacturing
Figure 10. Product Picture of Contract Manufacturing Organizations
Figure 11. Global Etoricoxib Intermediate Sales Market Share by Type in 2020
Figure 12. Global Etoricoxib Intermediate Revenue Market Share by Type (2016-2021)
Figure 13. Etoricoxib Intermediate Consumed in Rheumatoid Arthritis
Figure 14. Global Etoricoxib Intermediate Market: Rheumatoid Arthritis (2016-2021) & (MT)
Figure 15. Etoricoxib Intermediate Consumed in Psoriatic Arthritis
Figure 16. Global Etoricoxib Intermediate Market: Psoriatic Arthritis (2016-2021) & (MT)
Figure 17. Etoricoxib Intermediate Consumed in Osteoarthritis
Figure 18. Global Etoricoxib Intermediate Market: Osteoarthritis (2016-2021) & (MT)
Figure 19. Etoricoxib Intermediate Consumed in Ankylosing Spondylitis
Figure 20. Global Etoricoxib Intermediate Market: Ankylosing Spondylitis (2016-2021) & (MT)
Figure 21. Etoricoxib Intermediate Consumed in Chronic Low Back Pain
Figure 22. Global Etoricoxib Intermediate Market: Chronic Low Back Pain (2016-2021) & (MT)
Figure 23. Etoricoxib Intermediate Consumed in Acute Pain
Figure 24. Global Etoricoxib Intermediate Market: Acute Pain (2016-2021) & (MT)
Figure 25. Etoricoxib Intermediate Consumed in Others
Figure 26. Global Etoricoxib Intermediate Market: Others (2016-2021) & (MT)
Figure 27. Global Etoricoxib Intermediate Sales Market Share by Application (2016-2021)
Figure 28. Global Etoricoxib Intermediate Revenue Market Share by Application in 2020
Figure 29. Global Etoricoxib Intermediate Revenue Market by Company in 2020 ($ Million)
Figure 30. Global Etoricoxib Intermediate Revenue Market Share by Company in 2020
Figure 31. Global Etoricoxib Intermediate Sales Market Share by Regions (2016-2021)
Figure 32. Global Etoricoxib Intermediate Revenue Market Share by Region in 2020
Figure 33. Americas Etoricoxib Intermediate Sales 2016-2021 (MT)
Figure 34. Americas Etoricoxib Intermediate Revenue 2016-2021 ($ Millions)
Figure 35. APAC Etoricoxib Intermediate Sales 2016-2021 (MT)
Figure 36. APAC Etoricoxib Intermediate Revenue 2016-2021 ($ Millions)
Figure 37. Europe Etoricoxib Intermediate Sales 2016-2021 (MT)
Figure 38. Europe Etoricoxib Intermediate Revenue 2016-2021 ($ Millions)
Figure 39. Middle East & Africa Etoricoxib Intermediate Sales 2016-2021 (MT)
Figure 40. Middle East & Africa Etoricoxib Intermediate Revenue 2016-2021 ($ Millions)
Figure 41. Americas Etoricoxib Intermediate Sales Market Share by Country in 2020
Figure 42. Americas Etoricoxib Intermediate Revenue Market Share by Country in 2020
Figure 43. Americas Etoricoxib Intermediate Sales Market Share by Type in 2020
Figure 44. Americas Etoricoxib Intermediate Sales Market Share by Application in 2020
Figure 45. United States Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 46. Canada Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 47. Mexico Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 48. Brazil Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 49. APAC Etoricoxib Intermediate Sales Market Share by Region in 2020
Figure 50. APAC Etoricoxib Intermediate Revenue Market Share by Regions in 2020
Figure 51. APAC Etoricoxib Intermediate Sales Market Share by Type in 2020
Figure 52. APAC Etoricoxib Intermediate Sales Market Share by Application in 2020
Figure 53. China Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 54. Japan Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 55. Korea Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 56. Southeast Asia Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 57. India Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 58. Australia Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 59. Europe Etoricoxib Intermediate Sales Market Share by Country in 2020
Figure 60. Europe Etoricoxib Intermediate Revenue Market Share by Country in 2020
Figure 61. Europe Etoricoxib Intermediate Sales Market Share by Type in 2020
Figure 62. Europe Etoricoxib Intermediate Sales Market Share by Application in 2020
Figure 63. Germany Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 64. France Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 65. UK Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 66. Italy Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 67. Russia Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 68. Middle East & Africa Etoricoxib Intermediate Sales Market Share by Country in 2020
Figure 69. Middle East & Africa Etoricoxib Intermediate Revenue Market Share by Country in 2020
Figure 70. Middle East & Africa Etoricoxib Intermediate Sales Market Share by Type in 2020
Figure 71. Middle East & Africa Etoricoxib Intermediate Sales Market Share by Application in 2020
Figure 72. Egypt Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 73. South Africa Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 74. Israel Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 75. Turkey Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 76. GCC Country Etoricoxib Intermediate Revenue Growth 2016-2021 ($ Millions)
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles


★調査レポート[世界のエトリコキシブ中間体市場予測 2021年-2026年] (コード:LPI21MY9526)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のエトリコキシブ中間体市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆